Welcome to our dedicated page for BHTG news (Ticker: BHTG), a resource for investors and traders seeking the latest updates and insights on BHTG stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BHTG's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BHTG's position in the market.
BioHiTech Global (NASDAQ:BHTG) will present at the LD Micro 500 Virtual Conference on September 3, 2020, at 3:40 PM EDT. The conference runs from September 1-4, 2020. BioHiTech focuses on sustainable technology for waste management, offering solutions to reduce environmental impact. A live audio webcast of the presentation will be available, with details provided in the press release. For more information about their solutions, visit biohitech.com.
BioHiTech Global, Inc. (BHTG) reported Q2 2020 financial results, achieving a 21.2% revenue growth to $1.3 million compared to Q2 2019. The growth was driven by the HEBioT facility's revenue increase, which grew over threefold year-over-year. Despite this, operating expenses rose by 22.2% to $3.64 million, contributing to a net loss of $(2.66 million) or $(0.16) per share. The company secured a $8.2 million underwritten common stock offering and received purchase orders from Carnival Cruise Lines valued at approximately $1 million.
BioHiTech Global, Inc. (NASDAQ: BHTG) announced a new purchase order from Carnival Corporation, adding to its previous orders totaling approximately $1 million in July. This order will equip Carnival's new Mardi Gras ship, set to launch in February 2021, with multiple Revolution Series Digesters aimed at reducing greenhouse gas emissions and improving waste disposal. The existing contract with Carnival has an estimated total value of up to $14 million. BioHiTech's CEO highlighted the strategic partnership's potential for long-term value creation.
BioHiTech Global, Inc. (Nasdaq: BHTG) has completed its underwritten public offering of 4,550,000 shares of common stock at $1.81 per share, raising approximately $8.2 million. The offering included an option for Maxim Group LLC to purchase an additional 682,500 shares to cover over-allotments. The shares were offered under a previously effective SEC registration statement. BioHiTech aims to enhance its sustainable waste management solutions, which include converting municipal solid waste into renewable fuel.
BioHiTech Global, Inc. (Nasdaq: BHTG) announced a public offering of 4,550,000 shares at $1.81 each, raising approximately $8.2 million. Maxim Group LLC leads the underwriting team, with an additional 682,500 shares available for purchase. This offering is part of an effective shelf registration statement filed with the SEC. BioHiTech specializes in sustainable waste management solutions that reduce disposal costs and carbon footprints.
BioHiTech Global, Inc. (Nasdaq: BHTG) has announced an underwritten public offering of its common stock, subject to market conditions. This offering is made under an effective shelf registration statement filed with the SEC in December 2018. A preliminary prospectus supplement detailing the offering's terms will be filed shortly. The company cautions that there is no guarantee regarding the completion of the offering or its terms.
BioHiTech Global (NASDAQ: BHTG) has expanded its financing relationship with Crestmark and US Equity Funding to include equipment lease financing for the Altapure AP-4™ disinfecting system. This initiative aims to make the technology more affordable for markets like healthcare, hospitality, and education, particularly in the post-COVID environment. Financing is contingent on business credit approval. The Altapure AP-4™ is designed for high-level disinfection, effectively killing various pathogens including COVID-19.
BioHiTech Global (NASDAQ: BHTG) has appointed Walter Littlejohn III as an independent member of its Board of Directors. Littlejohn, with 29 years in the travel industry, is currently Senior Vice President at Crystal River Cruises. His background includes significant roles at Expedia and Carnival Cruise Lines, contributing to brand marketing and revenue management. CEO Frank E. Celli expressed that Littlejohn’s experience will enhance BioHiTech's leadership and aid in expanding its environmentally friendly technology solutions, particularly in the hospitality sector.
BioHiTech Global (NASDAQ: BHTG) reported Q1 2020 revenue of $1.4 million, an 84.3% increase from $738,000 in Q1 2019, primarily driven by its new Martinsburg facility. The company secured a purchase contract with Carnival Corp worth up to $14 million, although deployment delays occurred due to COVID-19. Operating expenses rose 41.2% to $3.75 million, resulting in a net loss of $2.57 million, or $(0.16) per share. Despite challenges, BioHiTech is optimistic about future growth and has raised $1.5 million in equity capital to support its initiatives.
BioHiTech Global (NASDAQ: BHTG) announced the commencement of live product demonstrations for its Altapure AP-4 high-level disinfectant. Following a distribution agreement from May, the Company is engaging potential customers in healthcare, hospitality, and education sectors. While no purchase orders have been secured yet, the early interest is promising. The AP-4 system, designed for effective disinfection against a range of pathogens, could play a crucial role in post-COVID-19 safety protocols. BioHiTech aims to enhance environmental management through its innovative solutions.
